• Home
  • Contact Us
  • About us
    • Company
    • Our Vision
    • Management Team
    • Partnerships and Collaborations
    • Partnership Program
    • Contact Us
  • Project Prodigy
  • Vizit
  • Solutions
    • Overview
    • Biovista Vizit
    • Drug Repositioning
    • Personalized Medicine
    • Drug De-risking
    • Clinical Hold
    • Pipeline
      • Overview
      • Neurodegenerative Diseases
      • CNS
      • Oncology
    • For Stakeholders
      • Biotech/Pharma Companies
      • Generics Companies
      • Patient Advocacy Groups
  • Technology
    • Overview
    • Research
    • Collaborative Research
    • Publications
  • News
    • Blog
    • Events
    • Press Releases
    • Biovista Articles
    • Media coverage
    • Announcements
    • Vizit Blog

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista | Drug Positioning and Prioritization

Biovista | Drug Positioning and Prioritization

  • About us
    • Company
    • Our Vision
    • Management Team
    • Partnerships and Collaborations
    • Partnership Program
    • Contact Us
  • Project Prodigy
  • Vizit
  • Solutions
    • Overview
    • Biovista Vizit
    • Drug Repositioning
    • Personalized Medicine
    • Drug De-risking
    • Clinical Hold
    • Pipeline
      • Overview
      • Neurodegenerative Diseases
      • CNS
      • Oncology
    • For Stakeholders
      • Biotech/Pharma Companies
      • Generics Companies
      • Patient Advocacy Groups
  • Technology
    • Overview
    • Research
    • Collaborative Research
    • Publications
  • News
    • Blog
    • Events
    • Press Releases
    • Biovista Articles
    • Media coverage
    • Announcements
    • Vizit Blog

BioWorld: A Deep Dive into Pfizer’s Emerging Biotech Strategy

November 9, 2010Media coverage
BioWorld: A Deep Dive into Pfizer’s Emerging Biotech StrategyVassilis Virvilis2016-01-05T08:33:02+00:00

By Arlene Weintraub, BioWorld Insight

On Nov. 9, the company formed a research collaboration with Biovista Inc…

 

Read More…

Post navigation

← Pfizer Seeks New Indications Using Biovista Bioinformatics
Biovista Announces a Drug Repositioning Collaboration With Pfizer →

Categories

  • Announcements (15)
  • Biovista Articles (10)
  • Blog (12)
  • Events (35)
  • Media coverage (27)
  • Press Releases (22)
  • Vizit Blog (13)

Archive

  • February 2020
  • July 2019
  • March 2019
  • October 2018
  • September 2018
  • August 2018
  • January 2018
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • January 2017
  • November 2016
  • October 2016
  • April 2016
  • February 2016
  • December 2015
  • September 2015
  • June 2015
  • May 2015
  • March 2015
  • January 2015
  • November 2014
  • October 2014
  • June 2014
  • May 2014
  • December 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • December 2012
  • November 2012
  • October 2012
  • August 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • September 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • December 2010
  • November 2010
  • July 2010
  • June 2010
  • May 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • June 2009
  • May 2009
  • April 2009
  • February 2009
  • January 2009
  • November 2008
  • September 2008
  • June 2008
  • March 2008
  • October 2007
  • September 2007
  • January 2007
  • October 2006
  • January 2005
  • September 2004
  • April 2004
  • September 2003
  • August 2003
  • July 2003
  • May 2003
  • December 2002
  • October 2002

Biovista on Twitter

  • RT @NYASciences: Save 30% when you register before Oct 22nd for the #Repositioning2019 daylong symposium. Register here:… https://t.co/xdnHfWC8KC
  • @Biovista proudly participates in #BioJapan2019 in #Yokohama to discuss about #ArtificialIntelligence applications… https://t.co/AxmwJdrhBo
  • Aris Persidis will be speaking today @ 8th Annual Drug Repositioning & Repurposing Conference, Washington DC on… https://t.co/ewBbZ6Oskp

Recent Posts

  • Business Development Agent in Japan
  • High Throughput Layout and Copy Paste
  • Biovista in World’s Top 20 AI Drug Development Companies
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery
  • The increasing importance of predicting AEs & the role of Augmented Intelligence

Background Reading

Read Biovista's two contributed chapters in the book Drug Repositioning or read Biovista President's and 100 of the world's top futurists' reflections on Alvin Toffler's classic book "Future Shock" and insights into the future,

Drug repositioning bookAfter Shock book

or read Biovista CEO's interview on drug repositioning

Follow us

Contact us

USA
2421 Ivy Road,
Charlottesville, VA 22903, USA
T: +1.434.971.1141
F: +1.434.971.1144

E: info{at}biovista.com

Legal | Sitemap| Careers

© 2020 Biovista | Drug Positioning and Prioritization All Rights Reserved.